These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20104071)

  • 21. Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
    Kim JM; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Kang H; Yoon JS
    Int J Cardiol; 2016 Sep; 219():225-30. PubMed ID: 27336191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.
    Stein DJ; Andersen EW; Tonnoir B; Fineberg N
    Curr Med Res Opin; 2007 Apr; 23(4):701-11. PubMed ID: 17407626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
    Brunoni AR; Moffa AH; Sampaio-Junior B; Borrione L; Moreno ML; Fernandes RA; Veronezi BP; Nogueira BS; Aparicio LVM; Razza LB; Chamorro R; Tort LC; Fraguas R; Lotufo PA; Gattaz WF; Fregni F; Benseñor IM;
    N Engl J Med; 2017 Jun; 376(26):2523-2533. PubMed ID: 28657871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and Efficacy of a Resiliency Intervention for the Prevention of Chronic Emotional Distress Among Survivor-Caregiver Dyads Admitted to the Neuroscience Intensive Care Unit: A Randomized Clinical Trial.
    Vranceanu AM; Bannon S; Mace R; Lester E; Meyers E; Gates M; Popok P; Lin A; Salgueiro D; Tehan T; Macklin E; Rosand J
    JAMA Netw Open; 2020 Oct; 3(10):e2020807. PubMed ID: 33052404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.
    Papakostas GI; Fava M; Baer L; Swee MB; Jaeger A; Bobo WV; Shelton RC
    Am J Psychiatry; 2015 Dec; 172(12):1251-8. PubMed ID: 26085041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial.
    Belle SH; Burgio L; Burns R; Coon D; Czaja SJ; Gallagher-Thompson D; Gitlin LN; Klinger J; Koepke KM; Lee CC; Martindale-Adams J; Nichols L; Schulz R; Stahl S; Stevens A; Winter L; Zhang S;
    Ann Intern Med; 2006 Nov; 145(10):727-38. PubMed ID: 17116917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
    Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
    J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new quality of the therapy of anxiety and depression--escitalopram].
    Neznanov NG; Bortsov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):79-84. PubMed ID: 15792148
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical features and efficacy of escitalopram treatment for geriatric depression.
    Chen YM; Huang XM; Thompson R; Zhao YB
    J Int Med Res; 2011; 39(5):1946-53. PubMed ID: 22117998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U; Wade A; Andersen HF
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.
    Emslie GJ; Ventura D; Korotzer A; Tourkodimitris S
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):721-729. PubMed ID: 19465881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcendental Meditation for the improvement of health and wellbeing in community-dwelling dementia caregivers [TRANSCENDENT]: a randomised wait-list controlled trial.
    Leach MJ; Francis A; Ziaian T
    BMC Complement Altern Med; 2015 May; 15():145. PubMed ID: 25952550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Psychological Impact of COVID-19 Pandemic and Lockdown on Caregivers of People With Dementia.
    Altieri M; Santangelo G
    Am J Geriatr Psychiatry; 2021 Jan; 29(1):27-34. PubMed ID: 33153872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
    Emsley R; Ahokas A; Suarez A; Marinescu D; Dóci I; Lehtmets A; Milanova V; Lee MS; Didi R; Araszkiewicz A; Sulaiman AH; Blanchot FP; Crutel VS; Antoine C; Penelaud PF
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 29995359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.
    Knorr U; Vinberg M; Klose M; Feldt-Rasmussen U; Hilsted L; Gade A; Haastrup E; Paulson O; Wetterslev J; Gluud C; Gether U; Kessing L
    Trials; 2009 Aug; 10():66. PubMed ID: 19671139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting.
    Dolberg O; Larsson Lönn S; Kvist K
    Curr Med Res Opin; 2014 Jul; 30(7):1301-7. PubMed ID: 24628498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance study.
    Laux G; Friede M; Müller WE
    Pharmacopsychiatry; 2013 Jan; 46(1):16-22. PubMed ID: 22648305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P; Lönn SL; Overø KF
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.